Skip to content

Drug interactions

Netupitant-palonosetron + Rasagiline

Severity: Moderate

Netupitant-palonosetron and Rasagiline: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Palonosetron, a 5-HT3 antagonist, has been associated with serotonin syndrome when combined with serotonergic drugs, including MAO inhibitors. Rasagiline adds to serotonergic load, so agitation, autonomic instability, hyperthermia, tremor and neuromuscular hyperactivity are possible. The risk is low-frequency but potentially serious.

What this interaction means in plain words

Netupitant-palonosetron and Rasagiline can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Netupitant-palonosetron belongs to Gastrointestinal Tract; Rasagiline belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive serotonergic effects from MAO-B inhibition combined with 5-HT3 receptor antagonism, though the exact mechanism of 5-HT3 antagonist-related serotonin syndrome is not well established.

What to do

Monitor for signs of serotonin syndrome such as mental status change, clonus, hyperthermia and diarrhea when the combination is given, and stop the agents if it develops. Consider another antiemetic if the patient has risk factors for serotonin toxicity.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Netupitant-palonosetron and Rasagiline, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Netupitant-palonosetron with Rasagiline?

MediHelp rates the interaction as moderate. Netupitant-palonosetron and Rasagiline can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Palonosetron, a 5-HT3 antagonist, has been associated with serotonin syndrome when combined with serotonergic drugs, including MAO inhibitors. Rasagiline adds to serotonergic load, so agitation, autonomic instability, hyperthermia, tremor and neuromuscular hyperactivity are possible. The risk is low-frequency but potentially serious.

How serious is the interaction between Netupitant-palonosetron and Rasagiline?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for signs of serotonin syndrome such as mental status change, clonus, hyperthermia and diarrhea when the combination is given, and stop the agents if it develops. Consider another antiemetic if the patient has risk factors for serotonin toxicity.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in